Brian Groark

Chief Financial Officer at Genomenon.

Raised on Genomenon filings

$6M

of $10M offered across 1 Form D filing

Company

Biotech · Ann Arbor, MI

Curated literature evidence for interpreting gene variants

Curated literature evidence for interpreting gene variants

Genomenon Form D filings
Filed	Security	Sold of offered	Filing
Jul 30, 2026	Equity	$6M/ $10M	Form D

Also named on Genomenon filings